Logos Global Management LP Bio Xcel Therapeutics, Inc. Transaction History

Logos Global Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$29.06 - $38.83 $11.6 Million - $15.5 Million	-400,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$39.04 - $64.6 $1.17 Million - $1.94 Million	-30,000 Reduced 6.98%	400,000 $17.3 Million
Q4 2020 Feb 16, 2021	SELL	$42.46 - $56.58 $5.1 Million - $6.79 Million	-120,000 Reduced 21.82%	430,000 $19.9 Million
Q3 2020 Nov 16, 2020	BUY	$37.44 - $64.63 $9.36 Million - $16.2 Million	250,000 Added 83.33%	550,000 $23.8 Million
Q2 2020 Aug 14, 2020	BUY	$17.62 - $58.71 $5.29 Million - $17.6 Million	300,000 New	300,000 $15.9 Million

3.14M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $11.5M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.